Fujian Wanchen Biotechnology Co. Ltd (300972) — Net Asset Quality Index
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Net Asset Quality Index of 31.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥10.76 Billion minus total liabilities of CN¥7.34 Billion yields net assets of CN¥3.42 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Fujian Wanchen Biotechnology Co. Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Fujian Wanchen Biotechnology Co. Ltd Net Asset Quality Index Over Time (2019–2025)
This chart shows how Fujian Wanchen Biotechnology Co. Ltd's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 31.8%, representing net assets of CN¥3.42 Billion against total assets of CN¥10.76 Billion CNY. Explore Fujian Wanchen Biotechnology Co. Ltd (300972) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Fujian Wanchen Biotechnology Co. Ltd (300972) market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 25.4% | CN¥2.55 Billion | CN¥10.05 Billion | CN¥7.50 Billion | ▲ +5.2 pp |
| 2024 | 20.1% | CN¥1.46 Billion | CN¥7.25 Billion | CN¥5.79 Billion | ▲ +2.4 pp |
| 2023 | 17.7% | CN¥695.81 Million | CN¥3.93 Billion | CN¥3.23 Billion | ▼ -38.3 pp |
| 2022 | 56.0% | CN¥672.36 Million | CN¥1.20 Billion | CN¥528.79 Million | ▼ -19.6 pp |
| 2021 | 75.6% | CN¥652.71 Million | CN¥863.18 Million | CN¥210.47 Million | ▲ +14.8 pp |
| 2020 | 60.8% | CN¥400.65 Million | CN¥658.59 Million | CN¥257.94 Million | ▲ +8.2 pp |
| 2019 | 52.6% | CN¥344.82 Million | CN¥655.63 Million | CN¥310.81 Million | — |